Purpose Recent attempts to include adverse effects of pathogens on human health in life cycle assessment (LCA) have focused on integrating results obtained through quantitative microbial risk assessment (QMRA) as an impact category in LCA. This study aimed to investigate whether the use of QMRA can be an adequate way of integrating pathogen impact potential in LCA and to quantify how pathogen impact potential is affected by choices regarding model structure and mathematical relationships used. Methods This study was performed for the context of sewage sludge management and is based on pathogen concentrations in treated sludge reported in the literature. Eight reference pathogens were included in order to address important microbial groups. The pathogen impact potential associated with land application of sewage sludge was quantified based on a QMRA model for eight distinct exposure pathways. The modelling choices investigated were linearisation of dose-response and severity assessment and different modelling approaches and parameter choices in fate and exposure assessment.
Introduction
In the context of wastewater and sewage sludge management, human health risks associated with hazardous chemicals and Responsible editor: Ralph K. Rosenbaum
Electronic supplementary material The online version of this article (doi:10.1007/s11367-015-0996-2) contains supplementary material, which is available to authorized users. microorganisms present in wastewater and sewage sludge are of particular concern. The health risks related to particular wastewater and sewage sludge management options are commonly quantified in risk assessment studies (e.g., Brooks et al. 2012; Gale 2005; Schoen et al. 2014) . Toxic effects of chemicals on human health (human toxicity) have also been assessed in life cycle assessment (LCA) studies (for recent reviews of LCA studies in the context of wastewater and sewage sludge management, the reader is referred to Corominas et al. 2013 and Yoshida et al. 2013) , with a focus on wider impacted regions compared to local impacts addressed by risk assessment (RA) studies. Life cycle impact assessment (LCIA) models to assess human toxicity are under continuous development (Hauschild et al. 2013) . However, there are currently no standard LCIA models available for the inclusion of adverse effects of pathogens on human health (pathogen impact potential) in LCA. As a result, pathogen impact potential is rarely included in LCA studies.
In recent years, a number of attempts have been made to integrate quantitative microbial risk assessment (QMRA) results into an LCA framework (Aramaki et al. 2006; Harder et al. 2014; Heimersson et al. 2014; Kobayashi et al. 2015; Larsen et al. 2009 ). These studies essentially estimated the burden of disease associated with the exposure of humans to pathogens as a result of wastewater and sludge management operations for a varying number of pathogens and exposure pathways based on QMRA. Hereby, the burden of disease was expressed in terms of disability-adjusted life years (DALYs), a concept developed for the World Health Organisation (Murray 1994) . This pathogen-related burden of disease was then presented in an LCA framework and treated as an LCA impact category. Clearly, pathogen impact potential and human toxicity potential both represent potential impacts on human health and can be expressed in terms of DALYs (Gao et al. 2015) . But is the integration of QMRA results in an LCA framework an adequate way of addressing the adverse effects of pathogens on human health in LCA?
Traditionally, LCIA does not take into account the timespace distribution of stressors and effects. Currently available LCIA models for human toxicity of chemicals (e.g., the USEtox model) for instance usually are steady-state fugacity-based compartment models. The compartments included in fate assessment often represent compartments at larger spatial scales (e.g., the regional or global scale), although efforts are made to increase the level of spatial resolution and differentiation. Exposure assessment may not include occupational exposure and usually does not address different sub-populations ). Effect assessment is usually based on linear mathematical relationships. But more importantly, parameter values in fate and exposure assessment usually represent routine operations under realistic average conditions. This approach is in line with common practice in LCA, namely to base the comparison of the performance of different product or service systems, or different life cycle phases of a product or service system, on a typical situation when technical systems operate according to the design specifications.
When it comes to adverse effects of pathogens on human health, however, the operation conditions with significant impacts may be events where processes do not work as they are supposed to. These are the conditions commonly addressed in QMRA. Because of a significant variability in the procedures and locations used for wastewater and sewage sludge management, the assessment of pathogen risk using QMRA is usually characterised by a high level of spatial and temporal specificity regarding transport, fate and exposure conditions (Haas et al. 2014) . Exposure assessment often includes occupational, recreational, as well as residential activities. Moreover, many of the mathematical relationships used in effect assessment are nonlinear. In QMRA, parameter values in fate and exposure assessment often represent realistic worst-case conditions, aiming at identifying critical exposure pathways, exposure conditions and sub-populations (Haas et al. 2014 ). In the context of wastewater and sewage sludge management, the frequency of the occurrence of operating conditions where the system does not work according to the design specifications may warrant consideration of adverse effects of pathogens on human health also in LCA. In LCA, however, the focus is on the overall impact for a given human population rather than on risks for specific members of a given human population. When it comes to addressing adverse effects of pathogens on human health in LCA, two questions thus are of interest and are addressed by the present study.
The first question is whether the mathematical relationships and the model structure of QMRA can be simplified and made more generic, similar to the development of generic LCIA models for human toxicity of chemicals starting from mathematical relationships established within chemical RA. To this end, the aim of the present study was to identify and explore possible modifications to the mathematical relationships and model structure applied in QMRA. The modifications identified and investigated in this study were inspired by the model structure and mathematical relationships underlying the USEtox model Rosenbaum et al. 2011) . It should be noted that other LCIA methods for the characterisation of human toxicity, such as ReCiPe (Goedkoop et al. 2009 ), could have served as a starting point but were not considered different enough in structure to warrant further study.
The second question is how pathogen impact potential is affected by different modelling choices pertaining to the mathematical relationships and model structure applied. In the present study, this comparison was made for eight exposure pathways related to land application of sewage sludge. The context of land application of sewage sludge was chosen because it is considered one option for recycling nutrients to productive land, alongside a range of more technical alternatives that involve extraction of nutrients from sludge or from solids remaining after partial or complete sludge oxidation (e.g., supercritical water oxidation, incineration). Land application of sewage sludge has been debated in Sweden (Bengtsson and Tillman 2004) and elsewhere for many years due to concerns about inorganic pollutants (e.g., heavy metals), organic pollutants (e.g., industrial chemicals, pharmaceutical residues and hormones) and pathogens (e.g., bacteria, viruses and parasites) present in the sludge.
Based on the findings from the case study on sewage sludge management, the present study provides recommendations on how to include pathogen risk in LCA, also in contexts other than sewage sludge management.
Methods

Baseline model
The baseline model follows a classical QMRA approach where each exposure pathway is modelled individually and effect assessment is based on nonlinear dose-response relationships. Which model is used depends on the pathogen under consideration (Electronic Supplementary Material). Doseresponse relationships for pathogens describe the relationship between a given pathogen dose per exposure event (D e ) and the corresponding probability of infection (or illness) per exposure event (P e ). In QMRA, dose-response relationships for pathogens usually are represented by nonlinear mathematical relationships, such as the exponential model or a beta-Poisson model (Electronic Supplementary Material). The exposure pathways relevant for land application of sewage sludge as well as the mathematical relationships in the baseline model were largely based on Brooks et al. (2012) and Gale (2005) (further details are provided in the Electronic Supplementary Material). The number of individuals exposed (n ind ) and the frequency of exposure (f exp ) were largely based on Westrell et al. (2004) , who investigated a wastewater treatment system treating 12,500 m 3 wastewater per day on average (serving 28, 600 people), and consisting of primary and secondary treatment (activated sludge process with biological nitrificationdenitrification and chemical phosphorus removal), tertiary treatment (constructed wetland), anaerobic sludge digestion and land application of digested sewage sludge (further details are provided in the Electronic Supplementary Material). The reference pathogens included in the current study were Campylobacter jejuni, Salmonella enterica (nontyphi), Listeria monocytogenes, pathogenic Escherichia coli (strain O157:H7), human infectious Adenovirus, human infectious Enterovirus (represented by Coxsackie B virus), Giardia lamblia and Cryptosporidium spp. The receptors covered are adults and children (exposed to pathogens through accidental, intentional, or routine ingestion or dermal contact during occupational, recreational, or residential activities) (see Table 1 and Fig. 1 In the USEtox model, the dose-response relationships for chemicals are represented by a linear mathematical relationship. The human toxicological effect factor for chemicals is calculated under the assumption of linearity in dose-response between zero and the point ED 50 at which the lifetime disease probability is 0.5 (Huibregts et al. 2010) . In mathematical terms, the analogous modification to the baseline model would be the replacement of the exponential or beta-Poisson dose-response model with a linear one (Eq. (1)), where ID 50 represents the dose where the probability of infection (or illness) is 0.5.
The linearisation shown in Eq. (1) is expected to cause an underestimation of the probability of infection (or illness) for low pathogen doses (D e <ID 50 ) and an overestimation for high pathogen doses (D e >ID 50 ). For a graphical representation of the original (i.e., exponential or beta-Poisson) and the modified (i.e., linearised) dose-response models, see Fig. 2 and Electronic Supplementary Material.
It is important to realise that the probability of infection (or illness) per exposure event (P e ) can exceed 1 in Eq. (1). Also, the mathematical formulation of the linearised concentrationresponse model reported in the USEtox user manual (Huibregts et al. 2010 ) is unbounded, and it would appear that it extends linearly also for probabilities above 0.5 even though the assumption of linearity is applied only for disease probabilities below 0.5. In the case of human toxicity of chemicals, this is not an issue in practice, as the assessment concerns lifetime disease probabilities resulting from chronic exposure. The emissions of chemicals considered in a given LCA study only constitute marginal contributions well below a lifetime disease probability of 0.5. In the case of pathogen impact potential, however, the probability of infection (or illness) is related to acute effects, and the emission of pathogens considered in a given LCA study can easily reach above a disease probability of 0.5. When investigating pathogen impact potential, it is therefore useful to see linearisation of doseresponse relationships as consisting of two components: the actual linearisation on one hand and the removal of the upper boundary (i.e., P max =1) on the other hand. In order to be able to judge the effect of these two components individually, a piece-wise linearisation (Eq. (2)) was considered as an alternative to the full linearisation (Eq. (1)).
The piece-wise linearisation of the dose-response relationship (Eq. (2)) will henceforward be referred to as modification 1a, and it aimed at investigating the effect of changing the shape of the dose-response curve whilst retaining an upper boundary (i.e., P e,max =1) for the probability of infection or illness (P e ). The removal of the upper limit for the probability of infection or illness, leading to a full linearisation of the dose-response relationship (Eq. (1)), will henceforward be referred to as modification 1b.
Linearisation of severity assessment relationships (modification 2)
In order to convert the probability of infection or illness (P e ) per exposure event into a burden of disease, the first step is to calculate the annual probability of infection or illness (P a ), taking into account the number of exposure events of a certain type an individual is exposed to during a year (n e ). In mathematical terms, linearisation of severity assessment relationships corresponds to replacing Eq. (3) used in the baseline model with Eq. (4).
On a conceptual level, this modification implies that the annual probability of infection or illness (P a ) no longer represents the probability of one individual becoming subject to infection or illness once or more in a year (i.e., Eq. (3) counts an individual infected several times a year as one case of infection) but the actual number of infections, neglecting immunity effects and the duration of an infection (i.e., Eq. (4) counts an individual infected on two successive months as two cases of infection). For small probabilities of infection or illness per exposure event (P e ), the annual probabilities of infection or illness (P a ) calculated using Eqs. (3) and (4) and hence the annual number of cases of infection or illness (N a ) are nearly identical. For larger probabilities of infection or illness per exposure event (P e ), however, the results from Eq. (4) are much larger than from Eq. (3). Further, all humans in the respective region are assumed to be exposed to the steady-state concentrations by breathing air, drinking water and ingesting food products. No distinction is made between sub-populations. Given the set of exposure pathways considered in this study in the context of land application of sewage sludge, modification 3 consists of limiting the set of exposure pathways to the consumption of produce grown on sludge-amended land (exposure pathway E8 in Table 1 ). This exposure pathway is the only one considered in this study that is included in the USEtox model. In order to investigate the effect of modification 3, the model results for each model variant were reported separately for exposure pathway E8 in addition to the aggregated results for exposure pathways E1-E8 and E1-E7, respectively (Table 3) .
Different modelling approaches and parameter choices regarding exposure pathway E8
For exposure pathway E8, the effect of different modelling approaches and parameter choices was investigated. Particular attention was given to the assumptions regarding exposure parameters (i.e., amount of produce consumed per individual exposed, frequency of exposure, number of individuals exposed). Four scenarios were investigated (Table 4) . The parameterisation in scenarios S1 and S2 was based on Brooks et al. (2012) regarding the amount of vegetables (grown on sewage sludge-amended land) eaten per individual (r ing ) and based on Westrell et al. (2004) regarding the number of individuals exposed (n ind ) and the frequency of exposure through consumption (f exp ). In scenario S1, the decay time in soil (t s ) and on crops (t c ) were chosen to represent an ideal situation with nominal system performance (i.e., the system works as it is supposed to, the time lag between sludge spreading and harvesting is t s =90 days and the time lag between harvesting and consumption is t c =10d). In scenario S2, the decay time on soil and crops were chosen to represent a bypass situation (i.e., the time lag between sludge spreading and harvesting is t s =5 days, and the time lag between harvesting and consumption is t c =0 days).
The parameterisation in scenario S3 is based on Gale (2005) (r ing , n ind , f exp ). Gale (2005) assumed that 1,150,000 people in the UK consume vegetable crops (all year) grown on land treated with sewage sludge; this estimate was based on the application of 520,000 t of dry sewage sludge to agricultural land. In the current study, sewage sludge production is estimated to be 2150 t of dry sludge, based on the assumption of a sludge production of 75 kg per capita per year and 28,600 people connected to the treatment plant. Based on the study of Gale (2005) , hence assuming conditions similar to the UK, the number of people exposed in the present study would be 4750. The decay time in soil and on the crops were chosen to represent an ideal situation with nominal system performance. For scenarios S1-S3, the overall burden of disease could be calculated for each model variant (BL and M1-M4).
Scenario S4 represents a different approach and did not require the specification of the amount of vegetables (grown on sewage sludge-amended land) eaten per individual (r ing ), the frequency of exposure through consumption (f exp ), nor the number of individuals exposed (n ind ). Rather, this approach of calculating the burden of disease (BoD) associated with land application of sewage sludge started from the amount of pathogens emitted (p em ), which is a function of the pathogen concentration in the sewage sludge (c) and the application rate (AR). A fraction of these pathogens was assumed to remain infectious in the soil after decay processes (f s ), a sub-fraction of these transferred to the crop (f sc ), and yet another sub-fraction remained on the crop after further decay processes (f c ). Essentially, this approach was based on linear mathematical relationships and attempted to calculate an intake fraction (iF), which can then be multiplied with an effect factor (EF) based on ID 50 and the burden of disease per case of infection (BoD case ). The model variant applied to scenario S4 is referred to as model variant ALT and is represented in Eq. (5). For each model variant, the burden of disease was calculated and aggregated over all exposure pathways and reference pathogens (Table 3) . Modification 1a (i.e., linearisation of dose-response relationships while retaining the upper boundary of the probability of infection or illness) seemed to have little effect overall (M1 vs. BL). Modification 2 (i.e., linearisation of severity assessment relationships) increased the overall pathogen impact potential in model variants M2 and M3 by a factor of 7 compared to the baseline model variant BL. Modification 1b (i.e., full linearisation of doseresponse relationships) had the most pronounced effect, as the pathogen impact potential in model variant M4 was increased another factor of 84 compared to model variant M3. Note that these findings did not apply to all individual combinations of pathogen and exposure pathway but relate to the overall results.
Model implementation
Effects at the level of distinct combinations of pathogen and exposure pathway
For some distinct combinations of pathogen and exposure pathway, the different model variants provided similar results (see pathogens P2 and P7 in Fig. 3 ). For other combinations of pathogen and exposure pathway, however, deviations between (5) model variants were significant (see pathogen P1 in Fig. 3) . The detailed results obtained for the different model variants are provided in the Electronic Supplementary Material for every combination of pathogen and exposure pathway.
For exposure frequencies (f exp ) considerably above 1, linearisation of severity assessment (modification 2) led to a higher burden of disease estimate in model variant M2 in comparison to the baseline model variant BL and in model variants M3 and M4 in comparison to model variant M1. In other words, modelling one individual exposed ten times per year as ten individuals exposed once per year will yield a higher burden of disease estimate. This effect was more pronounced at higher exposure frequencies (f exp ) and at higher pathogen doses (D e ). For pathogen doses below (respectively above) ID 50 , as expected, piece-wise linearisation of the doseresponse relationship (i.e., linearisation with retaining the upper boundary of the probability of infection or illness) (modification 1a) led to a lower (respectively higher) burden of disease estimate in model variant M1 in comparison to the baseline model variant BL and in model variants M3 and M4 in comparison to model variant M2. Although linearisation of severity assessment (modification 2) and piece-wise linearisation of dose-response assessment (modification 1a) did have an effect on pathogen risk, this effect was relatively small.
The effect of the removal of the upper boundary of the probability of infection or illness as a result of full linearisation of dose-response assessment (modification 1b), however, was potentially significant. For combinations of pathogen and exposure pathway subject to high pathogen doses per individual exposed, the removal of the upper boundary for the probability of infection or illness (modification 1b) led to a considerably higher burden of disease estimate in model variant M4 in comparison to model variant M3 (particularly for exposure pathway E2).
3.2 The effect of adaptations to the overall model structure and variation in fate and exposure assessment For each model variant, the burden of disease was calculated for exposure pathways E1-E7, E1-E8 and E8 separately ( Table 3 ). The initial model parameterisation of exposure pathway E8 (scenario S1) essentially assumed that 500 individuals eat 292 g of contaminated vegetables twice a year and that vegetables are harvested 90 days after sludge application and eaten 10 days after harvest. For this model parameterisation, the contribution of exposure E8 was negligible. As there is more produce available from sludgeamended fields than consumed in this scenario, the analysis follows the implicit assumption that all remaining produce is free of pathogens. If exposure pathway E8 is parameterised differently (Table 4) , its contribution to the overall burden of disease becomes more significant, particularly for scenario S2 (bypass situation) and scenario S4 (alternative modelling approach using model variant ALT). Yet, it is difficult to draw general conclusions about the significance of exposure pathway E8 as also other exposure pathways may be modelled and parameterised differently.
Discussion
Sources of uncertainty
This study explored several modifications to the mathematical relationships and model structure underlying QMRA with intent to make the characterisation of pathogen impact potential more akin to traditional LCIA models for the characterisation of human toxicity potential. It is important to recall that this study is based on pathogen concentrations and a set of exposure pathways described in the literature rather than the actual pathogen concentrations and exposure pathways characteristic of a specific site. Therefore, different results may have been obtained if different sludge qualities or a different set of exposure pathways had been considered. Nevertheless, the main findings of this study regarding the effect of linearisation in effect assessment can be said to be robust towards these sources of uncertainty. Regarding fate and exposure assessment, this study indicated that the choice of exposure pathways, modelling approach and model parameterisation represent major sources of uncertainty. Different assumptions regarding model parameters (i.e., pathogen decay time, number of individuals exposed, frequency of exposure) strongly influenced the estimated pathogen risk. Although only one exposure pathway was investigated in detail regarding the effect of modelling approach and parameterisation, this finding is deemed to be valid also for other exposure pathways and contexts. Finally, a potentially relevant aspect that was not addressed in the present study is the use of dynamic model concepts that address immunity and secondary spread (Eisenberg et al. 2002 (Eisenberg et al. , 2004 (Eisenberg et al. , 2008 Soller 2009 ). Neither was specific attention given to the uncertainties related to the estimation of pathogen concentration in sewage sludge through different sampling procedures.
4.2 Towards good practice for the integration of pathogen risk in LCA
Linearisation of mathematical relationships not always possible
When addressing pathogen risks related to exposure pathways with relatively low pathogen doses per exposure event, linearisation of dose-response relationships appears possible. For example, for the consumption of produce grown on sludge-amended land, the calculation model for pathogen risk could be conceived in a manner similar to models for human toxicity of chemicals (e.g., the USEtox model). The use of linear mathematical relationships in effect assessment would enable the combination of an EF based on a linear dose-response relationship with a pathogen iF. Thus, for the consumption of produce grown on sludge-amended land, it would be possible to calculate a characterisation factor (CF) representing a certain sewage sludge application regime (i.e., a given application rate, decay rates and time lags between land application and harvest) (Eq. (5)). When addressing pathogen risks related to occupational exposures and other exposures with potentially higher pathogen doses per exposure event, however, full linearisation of dose-response relationships (modification 1b) appears inappropriate because it could lead to an overestimation of the pathogen impact potential by several orders of magnitude.
Implications for scaling to a functional unit
In LCA, scaling to a functional unit usually takes place before fate, exposure and effect assessment. In combination with LCIA models for human toxicity of chemicals, this is acceptable, as all mathematical relationships are linear and the emissions of chemicals considered in a given LCA study usually are marginal contributions to a lifetime disease probability. The situation is different for pathogens, where the effects considered are acute rather than chronic. In those cases where full linearisation of dose-response relationships is inappropriate for the estimation of pathogen impact potential, the nonlinearity implies that pathogen doses need to be expressed in absolute terms rather than as marginal increase. This, in turn, implies that pathogen emissions cannot be scaled to a functional unit before fate, exposure and effect assessment, as otherwise nonlinearities in the dose-response relationship would not be properly accounted for. Still, scaling to a functional unit is possible; it just needs to be done after effect assessment (Harder et al. 2015) .
Overall model structure and parameterisation
Broadly speaking, the assessment of adverse effects related to pathogens requires the identification of a set of exposure pathways to be considered in the analysis. For each exposure pathway, over the course of time, there occur a number of exposure events, during each of which the receptor is exposed to a certain pathogen dose (D e ). Furthermore, a certain number of individuals are affected, and specific individuals may get exposed once or more. This simply means that, for each exposure pathway considered in a given study, the corresponding exposure events can in principle be parameterised in different ways, reflecting different exposure conditions. For example, one parameterisation may represent nominal system performance while another parameterisation may represent periods of poorer system performance for the same exposure pathway. The usual rationale followed in a QMRA framework is to limit the analysis to one specific parameterisation of exposure event per exposure pathway. The parameters are chosen such as to reflect realistic worst-case circumstances in terms of the highest burden of disease per individual exposed. For this critical exposure event, the analyst defines the pathogen dose (D e ), the number of individuals exposed (n ind ) and the number of exposure events these individuals are exposed to during a year (f exp ). Considering that only one critical parameterisation of exposure event is perfectly acceptable and appropriate in a QMRA framework, yet there is a general move towards more stochastic assessments that cover a suite of reference pathogens (Sales-Ortells and Medema 2015).
In an LCA framework, however, considering only the parameterisation of exposure event with the highest burden of disease per individual exposed may not be appropriate. Say one worker gets exposed to a given pathogen dose, corresponding to a probability of infection of 0.7, once per year (event A1). Say another 20 workers each get exposed to a third of this pathogen dose, corresponding to a probability of infection of 0.3, once per year (event A2) through the same exposure pathway (exposure pathway A). In a QMRA framework, where the focus is on risks for specific members of a given human population, exposure event A1 clearly is the critical one. In an LCA framework, however, where the focus is on overall impact, exposure event A2 may be the critical one, as the larger number of people exposed may lead to a higher overall burden of disease despite the less critical parameterisation of this exposure event (from the perspective of one individual exposed).
Because LCA focuses on overall impacts (i.e., the overall burden of disease for pathogen impact potential), it would in principle be necessary to consider a broader set of parameterisations for each individual exposure event. This set of parameterisations may then reflect a variety of exposure conditions during both nominal system performance and periods of poorer system performance or system mismanagement (bypass situations). The different exposure conditions could then be weighted before including the results in an LCA framework.
Comparability of pathogen impact potential and human toxicity potential in an LCA framework
The QMRA model for pathogen risk investigated in this study covered more exposure pathways than the USEtox model for the assessment of chemical risk. Even if parameterised in accordance with the principles applied in an LCA framework, the pathogen risk estimated using such a QMRA model may therefore not be directly comparable with chemical risk estimated based on the USEtox model. Including a broader set of exposure pathways for pathogens than for chemicals may introduce bias if chemical risk and pathogen risk are compared to each other. Such bias would essentially result from the inclusion of certain exposure pathways for pathogen risk whilst the same exposure pathways are neglected for chemical risk. Hence, also the aggregation of the respective burden of disease estimates for pathogen risk and chemical risk may be problematic. It therefore appears worthwhile to investigate the influence of modelling choices also for chemical risk through a comparison of the chemical risks estimated using LCIA models such as the USEtox model with chemical risks estimated using a model structure more similar to QMRA. Such fate and transport models would be based on site-specific exposure pathways rather than multimedia fate and transport models covering larger spatial scales. Hence, using sitespecific data would provide a second perspective on the question whether the integration of pathogen impact potential (assessed using mathematical relationships based on QMRA) in an LCA framework alongside human toxicity potential (assessed using fugacity-based LCIA models) introduces bias.
Conclusions
When combining QMRA and LCA, analysts should be aware of the differences between the QMRA and LCA frameworks. Based on this study and previous expertise of the authors, we argue that the direct integration of the results of a QMRA study into an LCA framework can be problematic. However, the use of QMRA as a substitute for nonexistent LCIA models for the estimation of pathogen risk can be an adequate way of integrating pathogen risk in an LCA framework alongside LCIA models for the assessment of other potential impacts on human health, but generally only if the model is parameterised in accordance with the principles applied in the LCA framework. Hereby, analysts should be particularly careful when making assumptions regarding exposure conditions such as pathogen decay, the number of people exposed and the frequency of exposure. These assumptions strongly influence the estimated pathogen risk. Finally, analysts should carefully consider whether the quantification of chemical risks and pathogen risks needs to be based on a similar set of exposure pathways or rather on pathways of highest risk for each hazard class-with specific identification of such.
